RaQualia Pharma Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	3,241	3,340	3,714	3,675	2,345
Short-Term Investments	3.31	1	49	250	313
Cash & Short-Term Investments	3,244	3,341	3,763	3,925	2,658
Cash Growth	-2.90%	-11.21%	-4.13%	47.67%	25.79%
Receivables	1,928	689	603	602	1,205
Inventory	159.77	167	147	8	10
Prepaid Expenses	165.72	193	188	108	90
Other Current Assets	184.38	148	255	179	40
Total Current Assets	5,682	4,538	4,956	4,822	4,003
Property, Plant & Equipment	436.41	529	573	391	299
Long-Term Investments	546.9	607	1,306	1,020	897
Goodwill	3,700	3,865	-	-	-
Other Intangible Assets	32.85	37	30	24	33
Long-Term Deferred Tax Assets	64.81	78	5	-	-
Other Long-Term Assets	50.75	1	1	-	2
Total Assets	10,514	9,655	6,871	6,257	5,234
Accounts Payable	73.19	59	54	128	45
Accrued Expenses	58	69	54	60	63
Current Portion of Long-Term Debt	512.62	512	12	2	-
Current Portion of Leases	78.74	69	64	42	21
Current Income Taxes Payable	54.78	221	178	237	230
Current Unearned Revenue	147.41	-	-	-	-
Other Current Liabilities	350.27	257	27	24	41
Total Current Liabilities	1,275	1,187	389	493	400
Long-Term Debt	2,139	2,651	39	9	-
Long-Term Leases	171.72	218	251	167	17
Long-Term Deferred Tax Liabilities	-	-	-	2	16
Other Long-Term Liabilities	32.39	28	73	89	15
Total Liabilities	3,618	4,084	752	760	448
Common Stock	3,241	2,720	2,667	2,265	2,256
Additional Paid-In Capital	3,431	2,910	2,857	2,455	2,446
Retained Earnings	227.44	-45	449	773	49
Treasury Stock	-0.1	-	-	-	-
Comprehensive Income & Other	-2.64	-14	146	4	35
Shareholders' Equity	6,896	5,571	6,119	5,497	4,786
Total Liabilities & Equity	10,514	9,655	6,871	6,257	5,234
Total Debt	2,902	3,450	366	220	38
Net Cash (Debt)	342.38	-109	3,397	3,705	2,620
Net Cash Growth	-	-	-8.31%	41.41%	26.69%
Net Cash Per Share	14.24	-5.04	157.22	176.57	124.93
Filing Date Shares Outstanding	24.46	21.84	21.62	21.6	20.96
Total Common Shares Outstanding	24.46	21.84	21.62	20.98	20.95
Working Capital	4,407	3,351	4,567	4,329	3,603
Book Value Per Share	281.96	255.10	282.98	262.05	228.43
Tangible Book Value	3,163	1,669	6,089	5,473	4,753
Tangible Book Value Per Share	129.34	76.43	281.60	260.90	226.86
Buildings	168.83	-	-	-	-
Machinery	1,422	-	-	-	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.